Trials / Completed
CompletedNCT04260516
The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- All
- Age
- 3 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The effect of N-acetylcysteine as antioxidant and its effect on pretransfusion hemoglobin and iron overload in patients with thalassemia were compared to patients who didn't receive n-acetylcysteine after 3 months of study duration
Detailed description
N-acetylcysteine( NAC) is a widely used mucolytic drug and several studies had reported its efficacy as anti oxidant. Patients with thalassemia major are at great risk for oxidative stress due to excess of b-globin chains and iron overload. In this study the investigators compared the effect of NAC on oxidative status , pretransfusion hemoglobin levels and iron overload in thalassemia patients before and after treatment with NAC for 3 months and with that of patients who served as controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetyl cysteine | Mucolytic and antioxidant drug |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2019-12-03
- Completion
- 2019-12-30
- First posted
- 2020-02-07
- Last updated
- 2020-02-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04260516. Inclusion in this directory is not an endorsement.